QMS Medical
QMS Medical Q4 FY26 earnings call: Revenue & Margins
Q4 FY26 earnings call: what management guided on revenue, margins and order book.
What the Q4 FY26 call signalled
4 of 4 strong
The short version
Target to increase revenue from camps from INR13 crores in FY26 to approximately INR18-20 crores in FY27. QMS Medical Allied Services targets to increase service revenue from INR 50 crores in FY26 to around INR 100 crores by FY27, mainly driven by patient service programs and camps. - Revenue from camps is expected to grow from approx.
From QMS Medical's Q4 FY26 earnings-call transcript · updated 25 Aug 2026.
Revenue & Sales Performance
- Target to increase revenue from camps from INR13 crores in FY26 to approximately INR18-20 crores in FY27.
- Aim to double revenue from the services segment (camps and patient service programs) from around INR50 crores in FY26 to INR100 crores.
- Overall revenue guidance for FY27 remains around INR216 crores.
- Product segment expected to grow at 10-15% annually.
- Services segment growth driven by new contracts, especially with GLP-1 drug patient engagement programs.
- Plan to expand number of camps (32,380 conducted in FY26), though not necessarily doubling camp count next year.
2 more points from QMS Medical's call on revenue
Pro opens every point from 15K+ earnings calls
Profitability & Margins
See what QMS Medical said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- The company is making significant investments in its service segment, focusing on people, infrastructure, and technology to double service revenue in FY26-27.
- Investments include hiring new employees (targeting 1,200 hires, with 800-850 already onboarded as of May) for patient service programs.
- Capital is being allocated to software development and data compliance systems to meet DPDP Act requirements and enhance service capabilities.
- These investments involve intangible assets such as people and custom software, which are expensed currently rather than capitalized.
2 more points from QMS Medical's call on capex
Pro opens every point from 15K+ earnings calls
Top-ranked in Healthcare Equipment & Supplies
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what QMS Medical said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- The company experienced order delays in Q3 and Q4 FY26, primarily on the product segment, due to supply chain and shipping disruptions.
- Some March orders were pushed into April and May.
- Management expects smoother order flow and positive growth in Q1 and Q2 FY27 compared to the previous year.
2 more points from QMS Medical's call on order book
Pro opens every point from 15K+ earnings calls
QMS Medical — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹37 Cr, net profit ₹3 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What QMS Medical Allied Services Ltd's management said in earlier quarters
Others in Healthcare Equipment & Supplies this season
- Q-Line Biotech Ltd (Q4 FY26)
Shift towards more manufacturing with gross margins of 60-65% for reagents supporting profitability improvement (Page 7, 6). Key concall takeaways from Q-Line…
- Vasa Denticity Ltd (Q4 FY26)
The company has a debt line of ₹15 crore available from financial partners. Key concall takeaways from Vasa Denticity Ltd's Q4 FY26 earnings call — and how it…
- Tarsons Products Ltd (Q4 FY26)
Margins may face pressure short-term due to raw material price volatility but should stabilize around current levels (gross margin not below 65%). Key concall…
- Laxmi Dental Ltd (Q4 FY26)
Export revenue (currently 33-34%) has tremendous potential alongside domestic; focus will be opportunity-driven (Page 11). Key concall takeaways from Laxmi…
Arthneeti Pro · Annual
QMS Medical and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were QMS Medical Q4 FY26 results?
Target to increase revenue from camps from INR13 crores in FY26 to approximately INR18-20 crores in FY27. QMS Medical Allied Services targets to increase service revenue from INR 50 crores in FY26 to around INR 100 crores by FY27, mainly driven by patient service programs and camps. - Revenue from camps is expected to grow from approx.
What is QMS Medical share price analysis?
QMS Medical currently shows a moderate growth signal based on ranking data. The stock trades at a P/E of 26.7 with a market cap of ₹287 Cr. Investors should review the full earnings analysis for detailed insights.
Is QMS Medical planning capital expenditure?
The company is making significant investments in its service segment, focusing on people, infrastructure, and technology to double service revenue in FY26-27.
Keep QMS Medical on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.